Patents Assigned to Shanghai Public Health Clinical Center, Fudan University
  • Anti-vaccine using sendai virus as vector
    Patent number: 10828359
    Abstract: Provided in the present application are a recombinant sendai virus vector vaccine expressing immunodominant antigens of Mycobacterium tuberculosis, and can be used as therapeutic and preventive antituberculosis vaccine.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: November 10, 2020
    Assignees: Shanghai Public Health Clinical Center, Fudan University, ID Pharma Co., Ltd.
    Inventors: Xiao-Yong Fan, Tsugumine Shu, Zhi-Dong Hu, Douglas B. Lowrie
  • ANTI-MYCOBACTERIUM TUBERCULOSIS VACCINE USING SENDAI VIRUS AS VECTOR
    Publication number: 20180085449
    Abstract: Provided in the present application are a recombinant sendai virus vector vaccine expressing immunodominant antigens of mycobacterium tuberculosis, and can be used as therapeutic and preventive antituberculosis vaccine.
    Type: Application
    Filed: April 19, 2016
    Publication date: March 29, 2018
    Applicants: Shanghai Public Health Clinical Center, Fudan University, ID Pharma Co., Ltd.
    Inventors: Xiao-Yong Fan, Tsugumine Shu, Zhi-Dong Hu, Douglas B. Lowrie